These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35694929)

  • 21. Disentangling in-vivo microstructural changes of white and gray matter in mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis.
    Zhong S; Lou J; Ma K; Shu Z; Chen L; Li C; Ye Q; Zhou L; Shen Y; Ye X; Zhang J
    Brain Imaging Behav; 2023 Dec; 17(6):764-777. PubMed ID: 37752311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease.
    Gao Y; Sengupta A; Li M; Zu Z; Rogers BP; Anderson AW; Ding Z; Gore JC;
    PLoS One; 2020; 15(10):e0240513. PubMed ID: 33064765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Free water in gray matter linked to gut microbiota changes with decreased butyrate producers in Alzheimer's disease and mild cognitive impairment.
    Yamashiro K; Takabayashi K; Kamagata K; Nishimoto Y; Togashi Y; Yamauchi Y; Ogaki K; Li Y; Hatano T; Motoi Y; Suzuki M; Miyakawa K; Ishikawa D; Aoki S; Urabe T; Hattori N
    Neurobiol Dis; 2024 Apr; 193():106464. PubMed ID: 38452948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease.
    Wen MC; Ng A; Chander RJ; Au WL; Tan LC; Kandiah N
    Parkinsonism Relat Disord; 2015 May; 21(5):483-8. PubMed ID: 25753847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.
    Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White Matter Differences in Networks in Elders with Mild Cognitive Impairment and Alzheimer's Disease.
    Yang FPG; Bal SS; Lee JF; Chen CC
    Brain Connect; 2021 Apr; 11(3):180-188. PubMed ID: 32731749
    [No Abstract]   [Full Text] [Related]  

  • 27. Domain-specific cognitive effects of white matter pathology in old age, mild cognitive impairment and Alzheimer's disease.
    Kaskikallio A; Karrasch M; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 May; 27(3):453-470. PubMed ID: 31198088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging.
    Lacalle-Aurioles M; Navas-Sánchez FJ; Alemán-Gómez Y; Olazarán J; Guzmán-De-Villoria JA; Cruz-Orduña I; Mateos-Pérez JM; Desco M
    J Alzheimers Dis; 2016; 50(4):1051-64. PubMed ID: 26890735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment.
    Ogama N; Endo H; Satake S; Niida S; Arai H; Sakurai T
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2045-2055. PubMed ID: 34585518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Magnetization Transfer of White Matter Tracts Correlates with Diffusion Tensor Imaging Indices in Predicting the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Makovac E; Serra L; Di Domenico C; Marra C; Caltagirone C; Cercignani M; Bozzali M
    J Alzheimers Dis; 2018; 63(2):561-575. PubMed ID: 29689722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A diagnostic index based on quantitative susceptibility mapping and voxel-based morphometry may improve early diagnosis of Alzheimer's disease.
    Sato R; Kudo K; Udo N; Matsushima M; Yabe I; Yamaguchi A; Tha KK; Sasaki M; Harada M; Matsukawa N; Amemiya T; Kawata Y; Bito Y; Ochi H; Shirai T
    Eur Radiol; 2022 Jul; 32(7):4479-4488. PubMed ID: 35137303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.
    van den Berg E; Geerlings MI; Biessels GJ; Nederkoorn PJ; Kloppenborg RP
    J Alzheimers Dis; 2018; 63(2):515-527. PubMed ID: 29630548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.
    Brueggen K; Dyrba M; Cardenas-Blanco A; Schneider A; Fliessbach K; Buerger K; Janowitz D; Peters O; Menne F; Priller J; Spruth E; Wiltfang J; Vukovich R; Laske C; Buchmann M; Wagner M; Röske S; Spottke A; Rudolph J; Metzger CD; Kilimann I; Dobisch L; Düzel E; Jessen F; Teipel SJ;
    J Neurol; 2019 Oct; 266(10):2465-2474. PubMed ID: 31227891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.
    Chwa WJ; Raji CA; Toups K; Hathaway A; Gordon D; Chung H; Boyd A; Hill BD; Hausman-Cohen S; Attarha M; Jarrett M; Bredesen DE
    J Alzheimers Dis; 2023; 96(3):1051-1058. PubMed ID: 38007669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. White matter changes from mild cognitive impairment to Alzheimer's disease: a meta-analysis.
    Qin L; Guo Z; McClure MA; Mu Q
    Acta Neurol Belg; 2021 Dec; 121(6):1435-1447. PubMed ID: 32170607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multiparametric MRI study of structural brain damage in dementia with lewy bodies: A comparison with Alzheimer's disease.
    Caso F; Agosta F; Scamarcia PG; Basaia S; Canu E; Magnani G; Volontè MA; Filippi M
    Parkinsonism Relat Disord; 2021 Oct; 91():154-161. PubMed ID: 34628194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant Cross-Tissue Functional Connectivity in Alzheimer's Disease: Static, Dynamic, and Directional Properties.
    Zhang X; Guan Q; Li Y; Zhang J; Zhu W; Luo Y; Zhang H;
    J Alzheimers Dis; 2022; 88(1):273-290. PubMed ID: 35570483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
    Kumar D; Vipin A; Wong B; Ng KP; Kandiah N
    Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer's disease: results from ADNI.
    Nabizadeh F; Balabandian M; Rostami MR; Kankam SB; Ranjbaran F; Pourhamzeh M;
    Aging Clin Exp Res; 2022 Oct; 34(10):2363-2372. PubMed ID: 35226303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.